Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI (NASDAQ:TEM) as the stock took a 15% ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

Key Takeaways Tempus AI's fourth-quarter results missed estimates as its costs increased.The medical technology firm's ...

Popular investor Cathie Wood and her Ark Invest funds took advantage of a buying opportunity on Tuesday by purchasing over 400,000 shares of ...

Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

Tempus AI Inc (NASDAQ:TEM) shares are trading lower Tuesday after the company reported mixed fourth-quarter financial results ...

EST Tempus AI (TEM) down 7% at $64.83 after Q4 earnings miss and guidanceDiscover the Best Stocks and Maximize Your Portfolio: See what ...

Despite optimistic news from the CEO yesterday afternoon, the company's shares fell overnight and a major investment house ...

Tempus AI saw its loss narrow in the fourth quarter despite booking higher costs and seeing a surge in revenue in the period. Shares fell 8.3% to $64 in post-market trading. Through Monday's close, ...